Morphing into cancer: The role of developmental signaling pathways in brain tumor formation

Journal of Neurobiology

Volumn 64, Issue 4, 2005, Pages 458-475

  Fogarty, Marie P ^a   Kessler, Jessica D ^a   Wechsler Reya, Robert J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BMP; Glioblastoma; Hedgehog; Medulloblastoma; Wnt

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; MORPHOGEN; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HUMAN; MEDULLOBLASTOMA; MISSENSE MUTATION; NERVOUS SYSTEM DEVELOPMENT; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TURCOT SYNDROME;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BRAIN; BRAIN NEOPLASMS; HEDGEHOG PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 23444457449     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/neu.20166     Document Type: Review

References (192)

1. Alcedo J, Ayzenzon M, Von Ohlen T, Noll M, Hooper JE. 1996. The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal. Cell 86:221-232.
2. Alder J, Lee KJ, Jessell TM, Hatten ME. 1999. Generation of cerebellar granule neurons in vivo by transplantation of BMP-treated neural progenitor cells. Nat Neurosci 2:535-540.
3. Attisano L, Wrana JL, Cheifetz S, Massague J. 1992. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68:97-108.
4. Aza-Blanc P, Lin HY, Ruiz i Altaba A, Kornberg TB. 2000. Expression of the vertebrate Gli proteins in Drosophila reveals a distribution of activator and repressor activities. Development 127:4293-4301.
5. Aza-Blanc P, Ramirez-Weber FA, Laget MP, Schwartz C, Kornberg TB. 1997. Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor. Cell 89:1043-1053.
6. Baeza N, Masuoka J, Kleihues P, Ohgaki H. 2003. AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22:632-636.
7. Bai CB, Auerbach W, Lee JS, Stephen D, Joyner AL. 2002. Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 129:4753-4761.
8. Balemans W, Van Hul W. 2002. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250:231-250.
9. Beghini A, Magnani I, Roversi G, Piepoli T, Di Terlizzi S, Moroni RF, Pollo B, Fuhrman Conti AM, Cowell JK, Finocchiaro G, et al. 2003. The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines. Oncogene 22:2581-2591.
10. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. 2003. Primary brain tumours in adults. Lancet 361:323-331.
11. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM, et al. 2002. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559-1561.
12. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, et al. 2003. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846-851.
13. Briscoe J, Pierani A, Jessell TM, Ericson J. 2000. A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell 101:435-445.
14. Brown JD, Moon RT. 1998. Wnt signaling: why is everything so negative? Curr Opin Cell Biol 10:182-187.
15. Buhren J, Christoph AH, Buslei R, Albrecht S, Wiestler OD, Pietsch T. 2000. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neuropathol Exp Neurol 59:229-240.
16. Cabrera CV, Alonso MC, Johnston P, Phillips RG, Lawrence PA. 1987. Phenocopies induced with antisense RNA identify the wingless gene. Cell 50:659-663.
17. Cadigan KM, Nusse R. 1997. Wnt signaling: a common theme in animal development. Genes Dev 11:3286-3305.
18. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. 1990. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847.
19. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P, Chen HL, Hoffer BJ, Wang Y. 2003. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34:558-564.
20. Chenn A, Walsh CA. 2002. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365-369.
21. Chenn A, Walsh CA. 2003. Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in beta-catenin overexpressing transgenic mice. Cereb Cortex 13:599-606.
22. Cliffe A, Hamada F, Bienz M. 2003. A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. Curr Biol 13:960-966.
23. Corrales JD, Rocco GL, Blaess S, Guo Q, Joyner AL. 2004. Spatial pattern of sonic hedgehog signaling through Gli genes during cerebellum development. Development 131:5581-5590.
24. Couso JP, Bate M, Martinez-Arias A. 1993. A wingless-dependent polar coordinate system in Drosophila imaginal discs. Science 259:484-489.
25. Dahmane N, Ruiz-i-Altaba A. 1999. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 126:3089-3100.
26. Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H, Ruiz i Altaba A. 2001. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 128:5201-5212.
27. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T. 2001. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61:7039-7043.
28. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. 1999. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85:485-491.
29. Delattre M, Briand S, Paces-Fessy M, Blanchet-Tournier MF. 1999. The Suppressor of fused gene, involved in Hedgehog signal transduction in Drosophila, is conserved in mammals. Dev Genes Evol 209:294-300.
30. Denef N, Neubuser D, Perez L, Cohen SM. 2000. Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell 102:521-531.
31. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J 17:3091-3100.
32. Dono R. 2003. Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol 284:R867-881.
33. Ebendal T, Bengtsson H, Soderstrom S. 1998. Bone morphogenetic proteins and their receptors: potential functions in the brain. J Neurosci Res 51:139-146.
34. Eberhart CG, Tihan T, Burger PC. 2000. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 59:333-337.
35. Echelard Y, Epstein DJ, St-Jacques B, Shen L, Mohler J, McMahon JA, McMahon AP. 1993. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell 75:1417-1430.
36. Eggenschwiler JT, Espinoza E, Anderson KV. 2001. Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway. Nature 412:194-198.
37. Ellison D. 2002. Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 28:257-282.
38. Erez A, Ilan T, Amariglio N, Muler I, Brok-Simoni F, Rechavi G, Izraeli S. 2002. GLB is not mutated commonly in sporadic medulloblastomas. Cancer 95:28-31.
39. Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM. 1991. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64:959-961.
40. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I, Sobol RE. 1996. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc Natl Acad Sci USA 93:2909-2914.
41. Fults D, Pedone C, Dai C, Holland EC. 2002. MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo. Neoplasia 4:32-39.
42. Furuta Y, Piston DW, Hogan BL. 1997. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 124:2203-2212.
43. Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R. 2000. Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 127:469-482.
44. Goodrich LV, Johnson RL, Milenkovic L, McMahon JA, Scott MP. 1996. Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes Dev 10:301-312.
45. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. 1997. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277:1109-1113.
46. Gorlin RJ. 1995. Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113-125.
47. Graham A, Francis-West P, Brickell P, Lumsden A. 1994. The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature 372:684-686.
48. Gurdon JB, Bourillot PY. 2001. Morphogen gradient interpretation. Nature 413:797-803.
49. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, et al. 1996. Mutations of the human homologue of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851.
50. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A. 1998. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 4:619-622.
51. Hall AC, Lucas FR, Salinas PC. 2000. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100:525-535.
52. Hall AK, Miller RH. 2004. Emerging roles for bone morphogenetic proteins in central nervous system glial biology. J Neurosci Res 76:1-8.
53. Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM. 2003. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9:1033-1038.
54. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, et al. 1995. The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847.
55. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
56. Heisenberg CP, Tada M, Rauch GJ, Saude L, Concha ML, Geisler R, Stemple DL, Smith JC, Wilson SW. 2000. Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation. Nature 405:76-81.
57. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. 2003. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178-15183.
58. Hogan BL. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
59. Hsu W, Zeng L, Costantini F. 1999. Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 274:3439-3445.
60. Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, Ohgaki H. 2000. APC mutations in sporadic medulloblastomas. Am J Pathol 156:433-437.
61. Hynes M, Porter JA, Chiang C, Chang D, Tessier-Lavigne M, Beachy PA, Rosenthal A. 1995. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 15:35-44.
62. Jennings MT, Pietenpol JA. 1998. The role of transforming growth factor beta in glioma progression. J Neurooncol 36:123-140.
63. Jia J, Tong C, Jiang J. 2003. Smoothened transduces Hedgehog signal by physically interacting with Costal2/ Fused complex through its C-terminal tail. Genes Dev 17:2709-2720.
64. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH, Jr., et al. 1996. Human homologue of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-1671.
65. Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W. 1998. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273:21145-21152.
66. Kalyani AJ, Piper D, Mujtaba T, Lucero MT, Rao MS. 1998. Spinal cord neuronal precursors generate multiple neuronal phenotypes in culture. J Neurosci 18:7856-7868.
67. Katayam M, Yoshida K, Ishimori H, Katayama M, Kawase T, Motoyama J, Kamiguchi H. 2002. Patched and smoothened mRNA expression in human astrocytic tumors inversely correlates with histological malignancy. J Neurooncol 59:107-115.
68. Katsetos CD, Herman MM, Krishna L, Vender JR, Vinores SA, Agamanolis DP, Schiffer D, Burger PC, Urich H. 1995. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med. Arch Pathol Lab Med 119:734-743.
69. Kawabata M, Imamura T, Miyazono K, Engel ME, Moses HL. 1995. Interaction of the transforming growth factor-beta type I receptor with farnesyl-protein transferase-alpha. J Biol Chem 270:29628-29631.
70. Kawano Y, Kypta R. 2003. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627-2634.
71. Kenney AM, Cole MD, Rowitch DH. 2003. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130:15-28.
72. Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS. 2004. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev 18:629-640.
73. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B. 1987. Identification of an amplified, highly expressed gene in a human glioma. Science 236:70-73.
74. Kishida S, Yamamoto H, Hino S, Ikeda S, Kishida M, Kikuchi A. 1999. DIX domains of Dv1 and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 19:4414-4422.
75. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. 1995. Histopathology, classification, and grading of gliomas. Glia 15:211-221.
76. Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M, Reifenberger J, Hartmann W, Friedl W, Reifenberger G, et al. 2001. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93:445-449.
77. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, et al. 1994. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14:5961-5974.
78. Korchynskyi O, ten Dijke P. 2002. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277:4883-4891.
79. Krauss S, Concordet JP, Ingham PW. 1993. A functionally conserved homologue of the Drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryos. Cell 75:1431-1444.
80. Kretzschmar M, Liu F, Hata A, Doody J, Massague J. 1997. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11:984-995.
81. Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. 2000. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16:279-283.
82. Lai K, Kaspar BK, Gage FH, Schaffer DV. 2003. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6:21-27.
83. Lam CW, Xie J, To KF, Ng HK, Lee KC, Yuen NW, Lim PL, Chan LY, Tong SF, McCormick F. 1999. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18:833-836.
84. LaMantia AS, Bhasin N, Rhodes K, Heemskerk J. 2000. Mesenchymal/ epithelial induction mediates olfactory pathway formation. Neuron 28:411-425.
85. Lee KS, Hong SH, Bae SC. 2002. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21:7156-7163.
86. Lee SM, Tole S, Grove E, McMahon AP. 2000. A local Wnt-3a signal is required for development of the mammalian hippocampus. Development 127:457-467.
87. Lee Y, Miller HL, Jensen P, Hernan R, Connelly M, Wetmore C, Zindy F, Roussel MF, Curran T, Gilbertson RJ, et al. 2003. A molecular fingerprint for medulloblastoma. Cancer Res 63:5428-5437.
88. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. 1999. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382-1390.
89. Lewis PM, Gritli-Linde A, Smeyne R, Kottmann A, McMahon AP. 2004. Sonic hedgehog signaling is required for expansion of granule neuron precursors and patterning of the mouse cerebellum. Dev Biol 270:393-410.
90. Li W, Cogswell CA, LoTurco JJ. 1998. Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. J Neurosci 18:8853-8862.
91. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN. 2003. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4:349-360.
92. Liem KF, Jr., Tremml G, Jessell TM. 1997. A role for the roof plate and its resident TGFbeta-related proteins in neuronal patterning in the dorsal spinal cord. Cell 91:127-138.
93. Liem KF, Jr., Tremml G, Roelink H, Jessell TM. 1995. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82:969-979.
94. Liu F, Pouponnot C, Massague J. 1997. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev 11:3157-3167.
95. Liu F, Ventura F, Doody J, Massague J. 1995. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479-3486.
96. Lum L, Zhang C, Oh S, Mann RK, von Kessler DP, Taipale J, Weis-Garcia F, Gong R, Wang B, Beachy PA. 2003. Hedgehog signal transduction via Smoothened association with a cytoplasmic complex scaffolded by the atypical kinesin, Costal-2. Mol Cell 12:1261-1274.
97. Mabie PC, Mehler MF, Kessler JA. 1999. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19:7077-7088.
98. Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG, Gritli-Linde A, Dellovade T, Porter JA, Rubin LL, et al. 2003. Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 39:937-950.
99. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL. 1998. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273:25628-25636.
100. Maniatis T. 1999. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev 13:505-510.
101. Marigo V, Johnson RL, Vortkamp A, Tabin CJ. 1996. Sonic hedgehog differentially regulates expression of GLI and GLI3 during limb development. Dev Biol 180:273-283.
102. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
103. McMahon AP, Bradley A. 1990. The Wnt-1 (int-1) protooncogene is required for development of a large region of the mouse brain. Cell 62:1073-1085.
104. McMahon AP, Joyner AL, Bradley A, McMahon JA. 1992. The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1-mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell 69:581-595.
105. Mehler MF, Mabie PC, Zhang D, Kessler JA. 1997. Bone morphogenetic proteins in the nervous system. Trends Neurosci 20:309-317.
106. Mehler MF, Mabie PC, Zhu G, Gokhan S, Kessler JA. 2000. Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev Neurosci 22:74-85.
107. Meng X, Poon R, Zhang X, Cheah A, Ding Q, Hui CC, Alman B. 2001. Suppressor of fused negatively regulates beta-catenin signaling. J Biol Chem 276:40113-40119.
108. Meyers EN, Martin GR. 1999. Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH. Science 285:403-406.
109. Mishina Y. 2003. Function of bone morphogenetic protein signaling during mouse development. Front Biosci 8:d855-869.
110. Monnier V, Dussillol F, Alves G, Lamour-Isnard C, Plessis A. 1998. Suppressor of fused links fused and Cubitus interruptus on the hedgehog signalling pathway. Curr Biol 8:583-586.
111. Moon RT, Bowerman B, Boutros M, Perrimon N. 2002. The promise and perils of Wnt signaling through beta-catenin. Science 296:1644-1646.
112. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691-701.
113. Mullins KJ, Rubio A, Myers SP, Korones DN, Pilcher WH. 1998. Malignant ependyrnomas in a patient with Turcot's syndrome: case report and management guidelines. Surg Neurol 49:290-294.
114. Neumann CJ, Cohen SM. 1997. Long-range action of Wingless organizes the dorsal-ventral axis of the Drosophila wing. Development 124:871-880.
115. Nguyen VH, Trout J, Connors SA, Andermann P, Weinberg E, Mullins MC. 2000. Dorsal and intermediate neuronal cell types of the spinal cord are established by a BMP signaling pathway. Development 127:1209-1220.
116. Nicot A, Lelievre V, Tam J, Waschek JA, DiCicco-Bloom E. 2002. Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J Neurosci 22:9244-9254.
117. Novak U, Walker F, Kaye A. 2001. Expression of EGFR-family proteins in the brain: role in development, health and disease. J Clin Neurosci 8:106-111.
118. Nusse R, Varmus HE. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99-109.
119. Nusslein-Volhard C, Wieschaus E. 1980. Mutations affecting segment number and polarity in Drosophila. Nature 287:795-801.
120. Ogden SK, Ascano M, Jr., Stegman MA, Suber LM, Hooper JE, Robbins DJ. 2003. Identification of a functional interaction between the transmembrane protein Smoothened and the kinesin-related protein Costal2. Curr Biol 13:1998-2003.
121. Oliver TG, Grasfeder LL, Carroll AL, Kaiser C, Gillingham CL, Lin SM, Wickramasinghe R, Scott MP, Wechsler-Reya RJ. 2003. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci USA 100:7331-7336.
122. Oliver TG, Wechsler-Reya RJ. 2004. Getting at the Root and Stem of Brain Tumors. Neuron 42:885-888.
123. Paraf F, Jothy S, Van Meir EG. 1997. Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol 15:2744-2758.
124. Park HL, Bai C, Platt KA, Matise MP, Beeghly A, Hui CC, Nakashima M, Joyner AL. 2000. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127:1593-1605.
125. Pasca di Magliano M, Hebrok M. 2003. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 3:903-911.
126. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J, Sorensen N, Berthold F, Henk B, Schmandt N, et al. 1997. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 57:2085-2088.
127. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. 2000. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407:535-538.
128. Podlasek CA, Barnett DH, Clemens JQ, Bak PM, Bushman W. 1999. Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev Biol 209:28-39.
129. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, et al. 2002. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442.
130. Pons S, Trejo JL, Martinez-Morales JR, Marti E. 2001. Vitronectin regulates Sonic hedgehog activity during cerebellum development through CREB phosphorylation. Development 128:1481-1492.
131. Porter JA, Young KE, Beachy PA. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255-259.
132. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, James CD. 1997. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57:842-845.
133. Rao G, Pedone CA, Coffin CM, Holland EC, Fults DW. 2003. c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 5:198-204.
134. Rao G, Pedone CA, Valle LD, Reiss K, Holland EC, Fults DW. 2004. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 23:6156-6162.
135. Remer S, Murphy ME. 2004. The challenges of long-term treatment outcomes in adults with malignant gliomas. Clin J Oncol Nurs 8:368-376.
136. Rich JN. 2003. The role of transforming growth factor-beta in primary brain tumors. Front Biosci 8:e245-260.
137. Rich JN, Bigner DD. 2004. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3:430-446.
138. Riddle RD, Johnson RL, Laufer E, Tabin C. 1993. Sonic hedgehog mediates the polarizing activity of the ZPA. Cell 75:1401-1416.
139. Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R. 1987. The Drosophila homologue of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50:649-657.
140. Rios I, Alvarez-Rodriguez R, Marti E, Pons S. 2004. Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development 131:3159-3168.
141. Roelink H, Porter JA, Chiang C, Tanabe Y, Chang DT, Beachy PA, Jessell TM. 1995. Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81:445-455.
142. Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL, et al. 2004. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6:229-240.
143. Rosen V, Wozney JM, Wang EA, Cordes P, Celeste A, McQuaid D, Kurtzberg L. 1989. Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. Connect Tissue Res 20:313-319.
144. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. 1995. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636.
145. Ruel L, Rodriguez R, Gallet A, Lavenant-Staccini L, Therond PP. 2003. Stability and association of Smoothened, Costal2 and Fused with Cubitus interruptus are regulated by Hedgehog. Nat Cell Biol 5:907-913.
146. Sander M, Paydar S, Ericson J, Briscoe J, Berber E, German M, Jessell TM, Rubenstein JL. 2000. Ventral neural patterning by Nkx homeobox genes: Nkx6.1 controls somatic motor neuron and ventral interneuron fates. Genes Dev 14:2134-2139.
147. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran WJ, Jr. 1998. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:51-55.
148. Sharma RP, Chopra VL. 1976. Effect of the Wingless (wgI) mutation on wing and haltere development in Drosophila melanogaster. Dev Biol 48:461-465.
149. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522-5527.
150. Singh SK, Clarke ID, Hide T, Dirks PB. 2004. Cancer stem cells in nervous system tumors. Oncogene 23:7267-7273.
151. Spencer FA, Hoffmann FM, Gelbart WM. 1982. Decapentaplegic: a gene complex affecting morphogenesis in Drosophila melanogaster. Cell 28:451-461.
152. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, et al. 1996. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384:129-134.
153. Stone DM, Murone M, Luoh S, Ye W, Armanini MP, Gurney A, Phillips H, Brush J, Goddard A, de Sauvage FJ, et al. 1999. Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci 112:4437-4448.
154. Taipale J, Beachy PA. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature 411:349-354.
155. Taipale J, Cooper MK, Maiti T, Beachy PA. 2002. Patched acts catalytically to suppress the activity of Smoothened. Nature 418:892-897.
156. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X. 2000. LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530-535.
157. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, et al. 2002. Mutations in SUFU predispose to medulloblastoma. Nat Genet 31:306-310.
158. Taylor MD, Zhang X, Liu L, Hui CC, Mainprize TG, Scherer SW, Wainwright B, Hogg D, Rutka JT. 2004. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling. Oncogene 23:4577-4583.
159. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH. 1994. Characterization of type I receptors for transforming growth factor-beta and activin. Science 264:101-104.
160. Thomas KR, Capecchi MR. 1990. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346:847-850.
161. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899-908.
162. Torres CF, Korones DN, Pilcher W. 1997. Multiple ependymomas in a patient with Turcot's syndrome. Med Pediatr Oncol 28:59-61.
163. Turcot J, Despres JP, St Pierre F. 1959. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465-468.
164. Urist MR. 1965. Bone: formation by autoinduction. Science 150:893-899.
165. Wallace VA. 1999. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol 9:445-448.
166. Wang B, Fallon JF, Beachy PA. 2000. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100:423-434.
167. Wang G, Wang B, Jiang J. 1999. Protein kinase A antagonizes Hedgehog signaling by regulating both the activator and repressor forms of Cubitus interruptus. Genes Dev 13:2828-2837.
168. Wang VY, Zoghbi HY. 2001. Genetic regulation of cerebellar development. Nat Rev Neurosci 2:484-491.
169. Wang Y, Chang CF, Morales M, Chou J, Chen HL, Chiang YH, Lin SZ, Cadet JL, Deng X, Wang JY, et al. 2001. Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke 32:2170-2178.
170. Watkins DN, Herman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. 2003. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313-317.
171. Wechsler-Reya R, Scott MP. 2001. The developmental biology of brain tumors. Annu Rev Neurosci 24:385-428.
172. Wechsler-Reya RJ, Scott MP. 1999. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog [see comments]. Neuron 22:103-114.
173. Weeraratna AT, Jiang Y, Hosteller G, Rosenblatt K, Duray P, Bittner M, Trent JM. 2002. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1:279-288.
174. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S. 2000. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407:527-530.
175. Westfall TA, Brimeyer R, Twedt J, Gladon J, Olberding A, Furutani-Seiki M, Slusarski DC. 2003. Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/beta-catenin activity. J Cell Biol 162:889-898.
176. Wilson SI, Rydstrom A, Trimborn T, Willert K, Nusse R, Jessell TM, Edlund T. 2001. The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature 411:325-330.
177. Wine-Lee L, Ahn KJ, Richardson RD, Mishina Y, Lyons KM, Crenshaw EB, 3rd. 2004. Signaling through BMP type 1 receptors is required for development of
178. Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
179. Wolter M, Scharwachter C, Reifenberger J, Koch A, Pietsch T, Reifenberger G. 2003. Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas. Acta Neuropathol (Berl) 106:287-290.
180. Yamada T, Pfaff SL, Edlund T, Jessell TM. 1993. Control of cell pattern in the neural tube: motor neuron induction by diffusible factors from notochord and floor plate. Cell 73:673-686.
181. Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH. 1994. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. J Biol Chem 269:20172-20178.
182. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K. 1995. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130:217-226.
183. Ye W, Shimamura K, Rubenstein JL, Hynes MA, Rosenthal A. 1998. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93:755-766.
184. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF. 1997. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol 17:7019-7028.
185. Yokota N, Nishizawa S, Ohta S, Dabe H, Sugimora H, Namba H, Maekawa M. 2002. Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 101:198-201.
186. Yoon JW, Liu CZ, Yang JT, Swart R, Iannaccone P, Walterhouse D. 1998. GLI activates transcription through a herpes simplex viral protein 16-like activation domain. J Biol Chem 273:3496-3501.
187. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617.
188. Zecca M, Basler K, Struhl G. 1996. Direct and long-range action of a wingless morphogen gradient. Cell 87:833-844.
189. Zechner D, Fujita Y, Hulsken J, Muller T, Walther I, Taketo MM, Crenshaw EB, 3rd, Birchmeier W, Birchmeier C. 2003. beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol 258:406-418.
190. Zhu AJ, Zheng L, Suyama K, Scott MP. 2003. Altered localization of Drosophila Smoothened protein activates Hedgehog signal transduction. Genes Dev 17:1240-1252.
191. Zurawel RH, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, de Sauvage F, Raffel C. 2000. Analysis of PTCH/ SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 27:44-51.
192. Zurawel RH, Chiappa SA, Allen C, Raffel C. 1998. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 58:896-899.